25
Views
3
CrossRef citations to date
0
Altmetric
Clinical Focus: Protocols and Treatment Options for Cardiovascular Disease

Different Treatment Interventions Affect Plasma NT-ProBNP Levels and Early Exercise Tolerance in Patients with Acute ST-Segment Elevation Myocardial Infarction

, MD, , MD, , PhD & , PhD
Pages 58-63 | Published online: 13 Mar 2015

References

  • . ; Canadian Cardiovascular Society; American Academy of Family Physicians; American College of Cardiology; American Heart AssociationAntman EM, Hand M, Armstrong PW, . 2007 focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2008;51(2):210–247
  • . Kwon TG, Bae JH, Jeong MH, ; Korea Acute Myocardial Infarction Registry Investigators. N-terminal pro-B-type natriuretic peptide is associated with adverse short-term clinical outcomes in patients with acute ST-elevation myocardial infarction underwent primary percutaneous coronary intervention. Int J Cardiol. 2009;133(2):173–178
  • . Szadkowska I, Goch JH, Polak L, Stepien H, Chizynski K. The relationship between early recanalization and serum NT-proBNP levels in patients with a first ST-segment elevation myocardial infarction treated with primary coronary angioplasty. Acta Cardiol. 2007;62(5):479–484
  • . Jang HL, Hun S P, Shung CC, ; Korea Acute Myocardial Infarction Registry Investigators. Predictors of six-month major adverse cardiac events in 30-day survivors after acute myocardial infarction (from the Korea Acute Myocardial Infarction Registry). Am J Cardiol. 2009;104(2):182–189
  • . James LJ, Roland VK, John L, . NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients: the International Collaborative of NT-proBNP Study. Eur Heart J. 2006;27(3): 330–337
  • . Valente S, Lazzeri C, Chiostri M, . NT-proBNP on admission for early risk stratification in STEMI patients submitted to PCI. Relation with extension of STEMI and inflammatory markers. Int J Cardiol. 2009;132(1):84–89
  • . Lorgis L, Zeller M, Dentan G, . Prognostic value of N-terminal pro-brain natriuretic peptide in elderly people with acute myocardial infarction: prospective observational study. BMJ. 2009;338:b1605
  • . Khan SQ, Dhillon O, Kelly D, . Plasma N-terminal B-type natriuretic peptide as an indicator of long-term survival after acute myocardial infarction: comparison with plasma midregional pro-atrial natriuretic peptide: the LAMP (Leicester Acute Myocardial Infarction Peptide) study. J Am Coll Cardiol. 2008;51(19):1857–1864
  • . Dzavík V, Buller CE, Lamas GA, . Randomized trial of percutaneous coronary intervention for subacute infarct-related coronary artery occlusion to achieve long-term patency and improve ventricular function: the Total Occlusion Study of Canada (TOSCA)-2 Trial. Circulation. 2006;114(23):2449–2457
  • . Blankenberg S, McQueen MJ, Smieja M, . Comparative impact of multiple biomarkers and N-terminal pro-brain natriuretic peptide in the context of conventional risk factors for the prediction of recurrent cardiovascular events in the Heart Outcomes Prevention Evaluation (HOPE) Study. Circulation. 2006;114(3):201–208
  • . Wu CJ, Chang H W, Hung WC, . N-terminal pro-brain natriuretic peptide is a biomarker of congestive heart failure and predictive of 30-day untoward clinical outcomes in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention. Circ J. 2006;70(2):163–168
  • . Szadkowska I, Goch JH, Kawinski J, Chizynski K. N-terminal pro-brain natriuretic peptide in the elderly with myocardial infarction. Clin Cardiol. 2008;31(9):443–447
  • . Etsuo M, Hirofumi Y, Michihiro, . Increased plasma levels of brain natriuretic peptide in patients with acute myocardial infarction. Circulation. 1993;88(1):82–91
  • . Davis ME, Richards AM, Nicholls MG, Yandle TG, Frampton CM, Troughton RW. Introduction of metoprolol increases plasma B-type cardiac natriuretic peptides in mild, stable heart failure. Circulation. 2006;113(7):977–985
  • . Drewniak W, Snopek G, Zarukiewicz M, Borys M, Dabrowski M. Prognostic value of the N-terminal pro-B-type natriuretic peptide in the elderly with acute myocardial infarction. Kardiol Pol. 2008;66(7):750–755
  • . Secil K, Aymelek G, Derya E, . Serum cardiac markers in patients with acute myocardial infarction: oxidative stress, C-reactive protein and N-terminal probrain natriuretic peptide. J Clin Biochem. 2007;41(1):50–57
  • . Ranjith N, Pegoraro RJ, Naidoo D P, Kaloo AS, Esterhuizen TM. The role of echocardiography and its comparison with NT-proBNP measurements in patients with acute myocardial infarction. Med Sci Monit. 2007;13(12):574–578

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.